Extrawell Pharmaceutical Holdings Limited (HKG:0858)

Market Cap	208.80M +78.3%
Revenue (ttm)	52.65M -11.4%
Net Income	-338.02M
EPS	-0.14
Shares Out	2.90B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	960,000
Open	0.0700
Previous Close	0.0720
Day's Range	0.0690 - 0.0700
52-Week Range	0.0480 - 0.1490
Beta	0.01
Analysts	n/a
Price Target	0.22 (+218.84%)
Earnings Date	Jun 30, 2026

About HKG:0858

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong. The company manufactures transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound he...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 161
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0858

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 22, 2026

Data Sources Report a data error